ad image

Oxford BioMedica

1 / 1
How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?
Digitalization

How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

Pharma's Almanac

PAO-06-24-RT-02Jun 24, 2024
What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?
Investment

What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?

Pharma's Almanac

PAO-06-24-RT-01Jun 24, 2024
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
Commitment to ESG Principles

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

Pharma's Almanac

PAO-03-24-CL-03Mar 08, 2024
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Accelerating Product Development

What strategies are being employed to accelerate product development and commercialization without compromising quality?

Pharma's Almanac

PAO-03-24-CL-02Mar 08, 2024
Boehringer Ingelheim
Partnership

Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford Biomedica Announce New Partnership

Boehringer Ingelheim

PR-M08-18-NI-049Aug 13, 2018
Oxford BioMedica is Making Big Moves
Cell and Gene Therapy

Oxford BioMedica is Making Big Moves

Emilie Branch

Pharma's Almanac

PAO-M03-18-NI-012Mar 13, 2018
1 / 1